Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opus Genetics Inc (IRD)

Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,889
  • Shares Outstanding, K 31,568
  • Annual Sales, $ 19,050 K
  • Annual Income, $ -9,990 K
  • EBIT $ -29 M
  • EBITDA $ -29 M
  • 60-Month Beta 0.19
  • Price/Sales 1.64
  • Price/Cash Flow N/A
  • Price/Book 0.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.09
  • Most Recent Earnings $-0.29 on 11/12/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 486.54% ( -488.99%)
  • Historical Volatility 102.60%
  • IV Percentile 61%
  • IV Rank 28.14%
  • IV High 975.53% on 12/19/24
  • IV Low 295.01% on 10/29/24
  • Put/Call Vol Ratio 1.25
  • Today's Volume 18
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 637
  • Open Int (30-Day) 620

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -61.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8100 +20.80%
on 12/18/24
1.2200 -19.80%
on 12/11/24
-0.0015 (-0.15%)
since 11/20/24
3-Month
0.8100 +20.80%
on 12/18/24
1.4300 -31.57%
on 09/23/24
-0.4115 (-29.60%)
since 09/20/24
52-Week
0.8100 +20.80%
on 12/18/24
3.3994 -71.22%
on 01/10/24
-1.6115 (-62.22%)
since 12/20/23

Most Recent Stories

More News
Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy

IRD : 0.9785 (-0.87%)
Opus Genetics to Host Virtual Key Opinion Leader Event on OPGx-LCA5 Gene Therapy for LCA5-Associated Inherited Retinal Disease

Opus Genetics announces a virtual KOL event on December 11, 2024, discussing efficacy and safety data on OPGx-LCA5 gene therapy.Quiver AI SummaryOpus Genetics, Inc. announced a virtual key opinion leader...

IRD : 0.9785 (-0.87%)
Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024

IRD : 0.9785 (-0.87%)
Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update

IRD : 0.9785 (-0.87%)
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

IRD : 0.9785 (-0.87%)
Proactive news headlines including Strategic Elements, Austral Gold, Westar Resources and Castillo Copper

Sydney, May 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

SOR : 45.31 (+2.14%)
AGD : 9.87 (+1.75%)
WSR : 14.26 (+0.07%)
VAL : 41.22 (+0.73%)
LOT : 3.65 (+3.40%)
LTSRF : 0.1115 (-1.33%)
CCZ : 60.40 (-0.58%)
CCZ.LN : 0.720 (-16.28%)
EEYMF : 0.0100 (+614.29%)
SKF : 35.68 (-2.70%)
SFIIF : 0.0016 (-30.43%)
IRD : 0.9785 (-0.87%)

Business Summary

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills,...

See More

Key Turning Points

3rd Resistance Point 1.1810
2nd Resistance Point 1.1405
1st Resistance Point 1.0595
Last Price 0.9785
1st Support Level 0.9380
2nd Support Level 0.8975
3rd Support Level 0.8165

See More

52-Week High 3.3994
Fibonacci 61.8% 2.4102
Fibonacci 50% 2.1047
Fibonacci 38.2% 1.7992
Last Price 0.9785
52-Week Low 0.8100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar